| Serial Number | 90890688 |
| Word Mark | KARRATIO |
| Filing Date | Wednesday, August 18, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 2, 2024 |
| Registration Number | 7257160 |
| Registration Date | Tuesday, January 2, 2024 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| Description of Mark | The mark consists of a circle design having three sections with colors of purple, orange and red and the word of "Karratio" in red. |
| Goods and Services | Pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cells, namely, chimeric antigen receptor T-cell (CAR-T), for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostral, murine, chimeric, humanized, human, monoclonal, and polyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells |
| Indication of Colors claimed | The color(s) purple, orange and red is/are claimed as a feature of the mark. |
| Goods and Services | Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 052, 051, 005, 018, 006, 044, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 6, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Eutilex Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08591 KR |
| Party Name | Eutilex Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08591 KR |
| Party Name | Eutilex Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08591 KR |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 29, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 26, 2023 | ASSIGNED TO LIE |
| Friday, April 14, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, March 30, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, March 30, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, March 30, 2023 | SUSPENSION INQUIRY WRITTEN |
| Friday, September 30, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, September 30, 2022 | LETTER OF SUSPENSION E-MAILED |
| Friday, September 30, 2022 | SUSPENSION LETTER WRITTEN |
| Tuesday, August 30, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 26, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, May 26, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, May 19, 2022 | ASSIGNED TO EXAMINER |
| Thursday, October 7, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, October 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 21, 2021 | NEW APPLICATION ENTERED |